Article
10 Oct 2025
TrumpRx: What Pharmacies And Plan Sponsors Need To Know
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
29 Sep 2025
AstraZeneca Doubles Down: Pharmacies Face Escalated Requests For Farxiga® Dispensing Records
Article
24 Sep 2025
Corresponding Responsibility: Why Pharmacies Must Take It Seriously — And How A Mock DEA Audit Can Protect Your Business
Article
22 Sep 2025
Iowa's PBM Oversight Laws: What Independent Pharmacies Need To Know
Article
11 Sep 2025
A Turning Point For Fiduciary Accountability: PBM-Owned Rebate Aggregators In The Spotlight
Article
03 Sep 2025
FDA's Removal Of Semaglutide And The Evolving Tirzepatide Decisions: What Compounders Need To Know
Article
28 Aug 2025
A Hard-Fought Victory: Overturning A Medicare Revocation For A Pennsylvania Pharmacy
Article
27 Aug 2025
Buchanan Pharmacy Attorneys Reverse 100% Of PBM Audit Findings
Article
08 Aug 2025
PBM Audits: Assessment Of Escalating Trends And Strategies For Pharmacies
Article
07 Aug 2025
Major Update On GLP-1 Litigation Involving Compounding Pharmacies
Article
01 Aug 2025
PBMs Double Down On Cross Network Termination Over "Affiliated" Pharmacies
Article
29 Jul 2025
The 340B Drug Pricing Program: Navigating Challenges In Healthcare Access
Article
29 Jul 2025
New Rules To Impact Texas Pharmacies
Article
24 Jul 2025
Victory For DMEPOS Provider: Buchanan Reverses Medicare Enrollment Revocation
Article
03 Jul 2025
Turning The Tide On Prior Authorization: A Legal And Strategic Moment For Independent Pharmacies
Article
19 Jun 2025
Pharmacy Alert: AstraZeneca Sends "Unreserved Cooperation" Letters Demanding Farxiga® Dispensing Records
Article
18 Jun 2025
State Board Of Pharmacy: Ohio GLP-1 Compounders Be Vigilant
Article
10 Jun 2025
Growing Concern For Pennsylvania Pharmacies: The Surge In State Board Inspections And The Collateral Impact On PBM Relationships
Article
03 Jun 2025
PBMs Under Siege: How The Current Administration's 2025 Executive Order And FTC Enforcement Campaign Are Shaping The Future Of Drug Pricing
Article
19 May 2025
Pharmacies On Alert: Gilead Reports Pharmacies To State Boards Over Counterfeit Drug Purchases
